IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Ekkehard Niemers

USPTO Granted Patents = 10

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:

goldMedal10 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1976-1987

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4636497 - Anti-thrombotic pharmaceutical compositions comprising (1987-01-13),
2. 4567188 - Hypotensive 2-nitro-1,1-ethenediamines (1986-01-28),
3. 4491595 - Combating fungi with trisubstituted cyanoguanidines (1985-01-01),
4. 4344955 - Penicillin 1,1-dioxides (1982-08-17),
5. 4344939 - Penicillin 1,1-dioxides, compositions thereof and methods of use (1982-08-17),
6. 4246260 - Substituted omicron-phenylenediamine derivatives, process for their (1981-01-20),
7. 4194004 - Substituted benzenesulphonic acid esters, processes for their (1980-03-18),
8. 4064270 - N'-(Aminoacylaminophenyl) acetamidines (1977-12-20),
9. 4015012 - 4-Acylaminophenylacetamidines and a method for their preparation (1977-03-29),
10. 3970699 - 4-Acylaminophenylacetamidines and a method for their preparation (1976-07-20),

Title: Ekkehard Niemers: Pioneering Innovator in Pharmaceutical Compositions

Introduction:

Ekkehard Niemers, a trailblazing inventor hailing from Wuppertal, Germany, has made an indelible mark in the field of pharmaceutical compositions. With an impressive portfolio of 10 patents to his name, Niemers is recognized for his relentless pursuit of innovation and commitment to pushing the boundaries of what is possible in the world of medicine.

Latest Patents:

Niemers' latest patents showcase his ingenuity in the development of cutting-edge pharmaceutical compositions. One of his groundbreaking inventions includes novel anellated 4H-1,4-benzothiazines, which serve as lipoxygenase-inhibiting agents in anti-thrombotic pharmaceutical compositions. Additionally, he has patented hypotensive 2-nitro-1,1-ethenediamines, revolutionizing the field with compounds designed to address cardiovascular health.

Career Highlights:

Niemers' illustrious career is anchored by his tenure at Bayer Aktiengesellschaft, a renowned pharmaceutical company at the forefront of innovation. Through his work at Bayer, Niemers has been instrumental in developing cutting-edge pharmaceutical compositions that have the potential to transform the landscape of healthcare.

Collaborations:

In his pursuit of excellence, Niemers has collaborated closely with esteemed colleagues such as Hartmund Wollweber and Herbert Thomas. Together, they have synergized their expertise to drive forward groundbreaking research and development initiatives, further cementing Niemers' reputation as a collaborative and visionary inventor.

Conclusion:

Ekkehard Niemers' unwavering dedication to innovation and his groundbreaking contributions to the field of pharmaceutical compositions have solidified his legacy as a trailblazing inventor. His relentless pursuit of excellence continues to inspire the next generation of innovators to push the boundaries of what is possible, shaping a brighter future for healthcare and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…